Meihao Medical Group Co., Ltd (HKG:1947)

Meihao Medical Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	81.94	90.25	78.49	86.83	89.53	41.28
Short-Term Investments	-	-	-	55.14	-	-
Cash & Short-Term Investments	81.94	90.25	78.49	141.97	89.53	41.28
Cash Growth	12.20%	14.97%	-44.71%	58.58%	116.87%	-19.01%
Accounts Receivable	1.88	0.82	0.69	0.79	0.52	0.6
Other Receivables	0.03	4.53	4.99	4.23	81.97	3.84
Receivables	1.91	5.35	5.68	5.02	82.49	4.44
Inventory	3.2	2.94	2.4	2.51	2.5	2.36
Other Current Assets	14.7	1.71	11.69	2.81	1.99	7.35
Total Current Assets	101.74	100.24	98.27	152.31	176.51	55.43
Property, Plant & Equipment	41.01	41.12	58.5	61.66	64.43	71.26
Long-Term Investments	14.08	-	10	-	-	-
Goodwill	11.49	11.49	11.49	-	-	-
Other Intangible Assets	0.3	0.32	0.49	0.37	0.53	0.53
Long-Term Deferred Tax Assets	0.12	0.12	0.23	0.69	5.21	3.56
Other Long-Term Assets	11.78	27.37	11.18	17.39	6.04	3.09
Total Assets	180.52	180.66	190.15	232.43	252.72	133.87

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	16.52	11.89	6.56	6.64	5.48	5.72
Accrued Expenses	-	9.13	7.77	6.8	7.2	7.52
Current Portion of Leases	3.91	3.38	8.25	8.8	6.9	9.38
Current Income Taxes Payable	0.16	0.24	1.56	1.49	8.87	8.91
Current Unearned Revenue	4	4	3.98	3.3	4.2	7.79
Other Current Liabilities	33.44	17.87	12	10.93	8.58	8.44
Total Current Liabilities	58.04	46.52	40.11	37.96	41.23	47.76
Long-Term Debt	-	12.4	-	-	-	-
Long-Term Leases	8.98	10.16	25.18	24.92	29.72	35.16
Long-Term Unearned Revenue	3.99	4.25	4.46	4.01	4.02	0.4
Long-Term Deferred Tax Liabilities	0.26	0.26	0.01	-	-	-
Total Liabilities	83.49	73.58	69.76	66.88	74.97	83.32

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.37	5.37	5.37	5.37	5.37	-
Additional Paid-In Capital	-	93.35	93.35	93.35	93.35	-
Retained Earnings	-	-9.76	6.8	44.67	58.26	29.81
Comprehensive Income & Other	90.51	16.86	13.82	21.79	20.39	20.47
Total Common Equity	95.88	105.82	119.34	165.18	177.37	50.28
Minority Interest	1.15	1.25	1.06	0.37	0.38	0.27
Shareholders' Equity	97.03	107.07	120.4	165.55	177.75	50.54
Total Liabilities & Equity	180.52	180.66	190.15	232.43	252.72	133.87

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.89	25.94	33.43	33.72	36.62	44.54
Net Cash (Debt)	69.04	64.31	45.06	108.25	52.91	-3.26
Net Cash Growth	64.70%	42.70%	-58.37%	104.58%	-	-
Net Cash Per Share	0.12	0.11	0.08	0.18	0.12	-0.01
Filing Date Shares Outstanding	582.77	600.15	600.15	600	600	450
Total Common Shares Outstanding	582.77	600.15	600.15	600	600	450
Working Capital	43.7	53.73	58.16	114.35	135.28	7.68
Book Value Per Share	0.16	0.18	0.20	0.28	0.30	0.11
Tangible Book Value	84.09	94.02	107.36	164.81	176.84	49.75
Tangible Book Value Per Share	0.14	0.16	0.18	0.27	0.29	0.11
Machinery	-	32.47	32.82	28.03	26.27	22.77
Construction In Progress	-	2.92	1.11	4.25	0.75	0.78
Leasehold Improvements	-	37.71	34.76	29.41	28.52	25.68

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 2, 2026

Data Sources Report a data error